Introduction
Current health-care spending is a crucial measure of the quality and accessibility of any country’s health-care system. It is feasible to examine and comprehend why the United States’ healthcare GDP is greater than that of most other nations by comparing current healthcare spending (as a percentage of GDP) in another country to current healthcare spending (as a percentage of GDP) in the United States. This analysis will shed light on the variables that contribute to the high cost of health care in the United States. Understanding the causes of discrepancies in healthcare spending can help establish more sustainable and equitable healthcare systems worldwide.
Health Spending and GDP in the US
According to the article “How Does Health Spending in the United States Compare to Other Countries?”, in 2020, health care spending in the U.S. was 18% of GDP, while other OECD (Organization for Economic Cooperation and Development) countries had much lower levels of health care spending(McGough et al., 2023). For example, healthcare spending in France accounted for 11.2% of GDP, in Germany for 11.5%, in the UK for 10%, and in Japan for 10.9% (McGough et al., 2023).
The high cost of medical services and drugs is one reason why the United States’ GDP for healthcare is higher. In the United States, healthcare is often a for-profit industry, where private healthcare professionals and pharmaceutical firms can charge exorbitant fees for services and products (Nunn et al., 2020). This raises the country’s overall healthcare costs.
Furthermore, the United States lacks a unified health-care system, which contributes to increased administrative and bureaucratic expenditures. Unlike in many other nations, where the state actively organizes and finances the healthcare system, the US healthcare system is private and commercial. This leads to a high degree of fragmentation and inconsistency in the health care system, as well as increased costs for administrative processes such as billing and insurance.
Furthermore, the US has a high level of medical consumption. Despite the U.S. having one of the highest healthcare costs, accessibility to healthcare services and medications remains an issue for many citizens (Galvani et al., 2020). This can lead to a higher demand for medical services and, consequently, higher healthcare costs. In addition, the US has a high level of technological advancement in the field of medicine. The U.S. has a large number of advanced medical technologies and treatments that may be more expensive compared to older and less advanced methods used in other countries. This can also lead to higher overall healthcare costs in the US.
Conclusion
The elevated price of medical care and pharmaceuticals is a key factor contributing to the higher share of GDP devoted to healthcare in the United States. Healthcare in the U.S. often operates as a profit-driven sector, allowing private providers and pharmaceutical companies to charge very high prices for medical services and medications (Nunn et al., 2020). As a result, total healthcare spending in the country increases.
Additionally, the absence of a centralized healthcare system results in higher administrative and bureaucratic costs. Unlike many countries where the government plays a central role in organizing and funding healthcare, the U.S. system is mainly private and commercially oriented. Furthermore, the lack of a unified healthcare system means that individuals often rely on private insurance, which can be expensive and contributes significantly to the country’s overall healthcare expenditure.
References
Galvani, A. P., Parpia, A. S., Foster, E. M., Singer, B. H., & Fitzpatrick, M. C. (2020). Improving the prognosis of health care in the USA. The Lancet, 395(10223), 524–533.
McGough, M., Telesford, I., Rakshit, S., Wager, E., Amin, K., & Cox, C. (2023). How does health spending in the U.S. compare to other countries? Peterson-KFF Health System Tracker.
Nunn, R., Parsons, J., Shambaugh, J., & Contreras, A. (2020). A dozen facts about the economics of the US health-care system. Brookings.